Login
Toggle navigation
Videos
Categories
Trending
Lori Woods, CEO of Isoray, Inc.
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Isoray Discusses CEO Transition, Vision for the Company and Value Catalysts Moving Forward
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Apollo's growth strategy, his views on alternative investments, and why he believes alts could soon make up 50 percent of individuals' portfolios|Marc Rowan, CEO and Co-Founder of Apollo Global Management
00:10:00
Childhood Memories: Free Cookies, Ramen, and McDonald's
00:10:00
Anthony Milewski on Base Metals' Bull Case Amid Market Shifts and ESG Focus
00:10:00
Sex Matters: Essays on Gender Critical Philosophy|Holly Lawford-Smith,Professor,University of Melbourne
00:10:00
Recent Drilling Results at AMEX Exploration's Perron Project
00:00:00
C4X Discovery Holdings PLC bags a billion molecules -Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding
00:10:00
Jonathan Buick on Idaho Champion Gold Mines' Projects and Prospects
00:10:00
Unlocking BVLOS Drone Delivery: How Elsight's Halo Ensured 99.9999% Uptime for DroneUp's Connectivity Needs |Yoav Amitai, CEO of Elsight
00:10:00
Inside the Minds of Wall Street's Titans: Insights and Predictions from Global Alts 2024
00:10:00
Overview of Element 29 Resources and Its Copper Projects in Peru
00:10:00
Client-Centric Financial Planning with John Sistina & Company
00:10:00
"Strategies for Tax-Free Retirement Income with Bruce Hosler, CFP® | Hosler Wealth Management"